Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks.

about

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Fluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis.

P2860

Q33862358-2D7C8244-3E6E-4F04-B5BB-CDA5E92448E6 Q33880939-272312E9-34CB-4D93-AAEA-13DA717DD6A3

P2860

Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks.

Item

http://www.wikidata.org/entity/Q38795329

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ultrafiltration Therapy for He ...... nefits against Possible Risks.

@en

type

Item

label

Ultrafiltration Therapy for He ...... nefits against Possible Risks.

@en

prefLabel

Ultrafiltration Therapy for He ...... nefits against Possible Risks.

@en

P1476

Ultrafiltration Therapy for He ...... nefits against Possible Risks.

@en

P2093

Amir Kazory

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Effect of nesiritide in patients with acute decompensated heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.

Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result.

P304

1463-1471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.13461215

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27034400

http://www.w3.org/2001/XMLSchema#string

P932

4974896

http://www.w3.org/2001/XMLSchema#string

Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks.

about

P2860

P2860

Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932